The University of Chicago Header Logo

Connection

Stephen Hanauer to Lymphoproliferative Disorders

This is a "connection" page, showing publications Stephen Hanauer has written about Lymphoproliferative Disorders.
  1. Review article: safety of infliximab in clinical trials. Aliment Pharmacol Ther. 1999 Sep; 13 Suppl 4:16-22; discussion 38.
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.